Decoy Therapeutics (DCOY) Cost of Revenue (2016 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Cost of Revenue of $36148.0 for Q2 2019, down 79.91% year-over-year from $179945.0 in Q2 2018, and down 23.62% quarter-over-quarter from $47329.0 in Q1 2019.
Decoy Therapeutics (DCOY) Cost of Revenue (2016 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Cost of Revenue for 4 consecutive years, with $36148.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Cost of Revenue fell 79.91% year-over-year to $36148.0; the TTM figure through Jun 2019 stood at $250348.0 (down 54.15% YoY), while the FY2018 annual figure was $430750.0, down 14.96% from the prior year.
- Cost of Revenue fell to $36148.0 in Q2 2019 per DCOY's latest filing, from $47329.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $221090.0 in Q3 2016 and bottomed at $36148.0 in Q2 2019.
- Historically, Cost of Revenue has averaged $120250.3 across 4 years, with a median of $122137.0 in 2016.
- Annual changes were most pronounced in 2017 — Cost of Revenue jumped 31.0% — and 2019, when it tumbled 79.91%.
- Decoy Therapeutics' Cost of Revenue stood at $133706.0 in 2016, then slipped by 0.27% to $133343.0 in 2017, then sank by 43.8% to $74934.0 in 2018, then plunged by 51.76% to $36148.0 in 2019.
- Business Quant data shows DCOY's Cost of Revenue at $36148.0 in Q2 2019, $47329.0 in Q1 2019, and $74934.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 36,148.00 |
| Jun 30, 2019 | 36,148.00 |
| Mar 31, 2019 | 47,329.00 |
| Mar 31, 2019 | 47,329.00 |
| Dec 31, 2018 | 74,934.00 |
| Dec 31, 2018 | 74,934.00 |
| Sep 30, 2018 | 91,937.00 |
| Sep 30, 2018 | 91,937.00 |
| Jun 30, 2018 | 179,945.00 |
| Jun 30, 2018 | 179,945.00 |
| Mar 31, 2018 | 83,934.00 |
| Mar 31, 2018 | 83,934.00 |
| Dec 31, 2017 | 133,343.00 |
| Dec 31, 2017 | 133,343.00 |
| Sep 30, 2017 | 148,756.00 |
| Sep 30, 2017 | 148,756.00 |
| Jun 30, 2017 | 145,325.00 |
| Jun 30, 2017 | 145,325.00 |
| Mar 31, 2017 | 79,106.00 |
| Mar 31, 2017 | 79,106.00 |